NO150117C - Analogifremgangsmaate for fremstilling av terapeutisk aktive prostaglandinderivater - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive prostaglandinderivater

Info

Publication number
NO150117C
NO150117C NO752675A NO752675A NO150117C NO 150117 C NO150117 C NO 150117C NO 752675 A NO752675 A NO 752675A NO 752675 A NO752675 A NO 752675A NO 150117 C NO150117 C NO 150117C
Authority
NO
Norway
Prior art keywords
ingrediates
prostagland
preparation
therapeutic active
analogy procedure
Prior art date
Application number
NO752675A
Other languages
English (en)
Norwegian (no)
Other versions
NO752675L (US20050065096A1-20050324-C00039.png
NO150117B (no
Inventor
Carmalo Gandolfi
Gianfederico Doria
Renato Pellegata
Maria M Usardi
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of NO752675L publication Critical patent/NO752675L/no
Publication of NO150117B publication Critical patent/NO150117B/no
Publication of NO150117C publication Critical patent/NO150117C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO752675A 1974-09-17 1975-07-29 Analogifremgangsmaate for fremstilling av terapeutisk aktive prostaglandinderivater NO150117C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2733374 1974-09-17

Publications (3)

Publication Number Publication Date
NO752675L NO752675L (US20050065096A1-20050324-C00039.png) 1976-03-18
NO150117B NO150117B (no) 1984-05-14
NO150117C true NO150117C (no) 1984-08-22

Family

ID=11221442

Family Applications (1)

Application Number Title Priority Date Filing Date
NO752675A NO150117C (no) 1974-09-17 1975-07-29 Analogifremgangsmaate for fremstilling av terapeutisk aktive prostaglandinderivater

Country Status (20)

Country Link
US (1) US4041064A (US20050065096A1-20050324-C00039.png)
JP (1) JPS5929075B2 (US20050065096A1-20050324-C00039.png)
BE (1) BE832891A (US20050065096A1-20050324-C00039.png)
CA (1) CA1098126A (US20050065096A1-20050324-C00039.png)
CH (2) CH614936A5 (US20050065096A1-20050324-C00039.png)
CS (1) CS191274B2 (US20050065096A1-20050324-C00039.png)
DE (1) DE2537406A1 (US20050065096A1-20050324-C00039.png)
DK (1) DK348575A (US20050065096A1-20050324-C00039.png)
FI (1) FI752303A (US20050065096A1-20050324-C00039.png)
FR (1) FR2313028A1 (US20050065096A1-20050324-C00039.png)
GB (2) GB1514543A (US20050065096A1-20050324-C00039.png)
HK (1) HK4079A (US20050065096A1-20050324-C00039.png)
HU (1) HU175345B (US20050065096A1-20050324-C00039.png)
IL (1) IL48027A (US20050065096A1-20050324-C00039.png)
MY (1) MY8000016A (US20050065096A1-20050324-C00039.png)
NL (1) NL7510191A (US20050065096A1-20050324-C00039.png)
NO (1) NO150117C (US20050065096A1-20050324-C00039.png)
SE (2) SE423992B (US20050065096A1-20050324-C00039.png)
SU (1) SU942588A3 (US20050065096A1-20050324-C00039.png)
ZA (1) ZA755310B (US20050065096A1-20050324-C00039.png)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4220759A (en) * 1975-03-14 1980-09-02 Carlo Erba S.P.A. 13,14-Dehydro-11-deoxy-prostaglandins and process for their preparation
HU178202B (en) * 1977-09-26 1982-03-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing new,optically active and racemic bicyclic acetals and merkaptals
US20090287003A1 (en) * 2005-09-29 2009-11-19 Jiang Xing Chen Process for the production of intermediates for making prostaglandin derivatives such as latanaprost, travaprost, and bimatoprost

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1425962A (en) * 1972-04-13 1976-02-25 Erba Carlo Spa Lactols and lactones

Also Published As

Publication number Publication date
NL7510191A (nl) 1976-03-19
SE7808849L (sv) 1978-08-22
IL48027A0 (en) 1975-11-25
GB1514543A (en) 1978-06-14
CA1098126A (en) 1981-03-24
FR2313028A1 (fr) 1976-12-31
JPS5929075B2 (ja) 1984-07-18
CH617424A5 (US20050065096A1-20050324-C00039.png) 1980-05-30
NO752675L (US20050065096A1-20050324-C00039.png) 1976-03-18
AU8350075A (en) 1977-02-03
SE7509607L (sv) 1976-03-18
NO150117B (no) 1984-05-14
DK348575A (da) 1976-03-18
HU175345B (hu) 1980-07-28
SU942588A3 (ru) 1982-07-07
GB1514542A (en) 1978-06-14
JPS5143745A (en) 1976-04-14
US4041064A (en) 1977-08-09
FR2313028B1 (US20050065096A1-20050324-C00039.png) 1980-05-30
FI752303A (US20050065096A1-20050324-C00039.png) 1976-03-18
SE423992B (sv) 1982-06-21
MY8000016A (en) 1980-12-31
IL48027A (en) 1980-03-31
BE832891A (fr) 1976-03-01
SE427556B (sv) 1983-04-18
HK4079A (en) 1979-01-26
CS191274B2 (en) 1979-06-29
ZA755310B (en) 1977-04-27
CH614936A5 (US20050065096A1-20050324-C00039.png) 1979-12-28
DE2537406A1 (de) 1976-08-12

Similar Documents

Publication Publication Date Title
NO143576C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser
NO149106C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzcykloamider
NO145691C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme decapeptidamider
NO141800C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner.
NO143460C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner.
NO151040C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-halogenpyrimid-2-oner
NO141207C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive fenylalkylaminer
NO142838C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater
SE421209B (sv) Analogiforfarande for framstellning av tienobensodiazepiner
NO141894C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive pyridobenzodiazepinoner
NO143064C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksyalkylxantiner
NO144108C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-benzylpiperid-4-yl)-benzamider
NO143625C (no) Analogifremgangsmaate for fremstilling av 2-metoksy-benzamider
NO145238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydrokarbostyril-derivater
NO145163C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive antitumorglykosider
NO148488C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive acyl-benzimidazol-2-derivater
NO147485C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 8-aminomethylisoflavonderivater
NO144704C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1-alkyl-2-(fenoksymetyl)-5-nitro-imidazoler
NO146672C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cinnolinderivater
NO145383C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte indoler.
NO143903C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-fluorpyrimidin-4-on-derivater
SE414028B (sv) Forfarande for framstellning av terapeutisk verksamma fentiazinderivat
NO144741C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiopyrano-pyrazoler
NO144019C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive naftyridinderivater
NO150117C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive prostaglandinderivater